Management of chemotherapy-induced side-effects
Author:
- Mukaila A RajiMRMukaila A Raji
- 1 June 2005
- journal article
- Published by Elsevier in The Lancet Oncology
- Vol. 6 (6) , 357
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoeaThe Lancet Oncology, 2005
- Mirtazapine (Remergil) for treatment resistant hyperemesis gravidarum: rescue of a twin pregnancyArchives of Gynecology and Obstetrics, 2003
- Management of symptons associated with advanced cancer: olanzapine and mirtazapineExpert Review of Anticancer Therapy, 2002
- Tolerability and safety aspects of mirtazapineHuman Psychopharmacology: Clinical and Experimental, 2002
- An Open-Label, Crossover Trial of Mirtazapine (15 and 30 mg) in Cancer Patients with Pain and Other Distressing SymptomsJournal of Pain and Symptom Management, 2002
- Venlafaxine and MirtazapineJournal of Molecular Neuroscience, 2002
- Depression in cancer patientsThe Lancet Oncology, 2001
- Mirtazapine for the Treatment of Depression and Nausea in Breast and Gynecological OncologyPsychosomatics, 2000